Results at 5 years of intra vesical gemcitabine (G) single agent as adjuvant chemotheray in superficial transitional cell carcinoma (TCC) of the bladder

被引：0
|
作者：
Smaili, F.
Bounedjar, A.
Ferhat, R.
Bouzid, K.
机构：
[1] Anticanc Ctr, Blida, Algeria
[2] CHU Tiziouzou, Tiziouzou, Algeria
[3] CPMC, Algiers, Algeria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16087
引用
收藏
页数：1
相关论文
共 50 条
  • [31] EXPRESSION OF C-ERBB(2) CORRELATES WITH TUMOR STAGE AND GRADE IN SUPERFICIAL TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER (TCC)
    TANNAPFEL, A
    KUHN, R
    SCHAFHAUSER, W
    WITTEKIND, C
    SCHROTT, KM
    [J]. AKTUELLE UROLOGIE, 1995, 26 : 71 - 74
  • [32] RECURRENT SUPERFICIAL TRANSITIONAL CELL-CARCINOMA OF THE BLADDER - ADJUVANT TOPICAL CHEMOTHERAPY VERSUS IMMUNOTHERAPY - A PROSPECTIVE RANDOMIZED TRIAL
    FLAMM, J
    BUCHER, A
    HOLTL, W
    ALBRECHT, W
    LAMM, DL
    [J]. JOURNAL OF UROLOGY, 1990, 144 (02): : 260 - 263
  • [33] A phase II trial of gemcitabine (G), carboplatin (C), and sorafenib (S) in patients (pts) with transitional cell carcinoma (TCC): Preliminary safety and outcome
    Mehnert, J. M.
    Mortazavi, A.
    Stein, M. N.
    Donadio, A. C.
    Zelterman, D.
    McDonough, J. A.
    Rowen, E.
    Hoimes, C. J.
    Gibney, G.
    Kelly, W. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [34] The long-term outcome in patients with superficial transitional cell carcinoma of the bladder:: a single-institutional experience
    Haukaas, S
    Dæhlin, L
    Maartmann-Moe, H
    Ulvik, NM
    [J]. BJU INTERNATIONAL, 1999, 83 (09) : 957 - 963
  • [35] REGRESSION OF TRANSITIONAL-CELL CARCINOMA OF THE BLADDER WITH RADIOTHERAPY - PROGRESSION-FREE CONTROL IN THE BLADDER AT 5 YEARS
    BESSELL, EM
    TAYLOR, J
    MOLONEY, AJ
    LEMBERGER, J
    [J]. RADIOTHERAPY AND ONCOLOGY, 1993, 29 (03) : 344 - 346
  • [36] Phase 1 dose-escalation trial of intravesical CG0070 for superficial transitional cell carcinoma (TCC) of the bladder after BCG failure
    Maslyar, Daniel J.
    McKiernan, James
    Nemunaitis, John
    Arseneau, James
    Stephenson, Joe
    Burke, James
    Neal, Kristina
    Aimi, Junko
    Lamm, Don
    [J]. JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 675 - 675
  • [37] The accuracy of visual detection of high-risk superficial bladder transitional cell carcinoma (TCC) after Bacillus-Calmette-Guerin (BCG) treatment
    Aw, I. H. C.
    Ranasinghe, W.
    Azer, S.
    Woodford, R.
    Mohotti, J.
    Cetti, R.
    Gibson, L.
    Webb, C.
    Bolton, D.
    Sengupta, S.
    Frydenberg, M.
    Appu, S.
    [J]. BJU INTERNATIONAL, 2015, 115 : 86 - 87
  • [38] ADJUVANT INTRAVESICAL MITOXANTRONE AFTER TRANSURETHRAL RESECTION OF PRIMARY SUPERFICIAL TRANSITIONAL-CELL CARCINOMA OF THE BLADDER - A PROSPECTIVE RANDOMIZED STUDY
    FLAMM, J
    DONNER, G
    OBERLEITNER, S
    HAUSMANN, R
    HAVELEC, L
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (02) : 143 - 146
  • [39] SINGLE POSTOPERATIVE INSTILLATION OF GEMCITABINE IN PATIENTS WITH SUPERFICIAL TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 MULTICENTER STUDY
    Boehle, Andreas
    Helsberg, Karin
    Luebben, Birgit
    Stoffregen, Clemens
    Buettner, Hartwig
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 689 - 689
  • [40] Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder
    Hungerhuber, Edwin
    Stepp, Herbert
    Kriegmair, Martin
    Stief, Christian
    Hofstetter, Alfons
    Hartmann, Arndt
    Knuechel, Ruth
    Karl, Alexander
    Tritschler, Stefan
    Zaak, Dirk
    [J]. UROLOGY, 2007, 69 (02) : 260 - 264
12345